Biomol Ther.  2016 Jul;24(4):446-452. 10.4062/biomolther.2015.197.

Pharmacokinetic Interaction of Chrysin with Caffeine in Rats

Affiliations
  • 1College of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea. taecheon@ynu.ac.kr
  • 2College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
  • 3College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea. hgjeong@cnu.ac.kr

Abstract

Pharmacokinetic interaction of chrysin, a flavone present in honey, propolis and herbs, with caffeine was investigated in male Sprague-Dawley rats. Because chrysin inhibited CYP1A-selective ethoxyresorufin O-deethylase and methoxyresorufin O-demethylase activities in enriched rat liver microsomes, the pharmacokinetics of caffeine, a CYP 1A substrate, was studied following an intragastric administration with 100 mg/kg chrysin. In addition to the oral bioavailability of chrysin, its phase 2 metabolites, chrysin sulfate and chrysin glucuronide, were determined in rat plasma. As results, the pharmacokinetic parameters for caffeine and its three metabolites (i.e., paraxanthine, theobromine and theophylline) were not changed following chrysin treatment in vivo, despite of its inhibitory effect on CYP 1A in vitro. The bioavailability of chrysin was found to be almost zero, because chrysin was rapidly metabolized to its sulfate and glucuronide conjugates in rats. Taken together, it was concluded that the little interaction of chrysin with caffeine might be resulted from the rapid metabolism of chrysin to its phase 2 metabolites which would not have inhibitory effects on CYP enzymes responsible for caffeine metabolism.

Keyword

Chrysin; Caffeine; Drug interaction; Pharmacokinetics; in vivo
Full Text Links
  • BT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr